Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Stock Information for Calyxt Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Calyxt Inc.

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
Innovative Medical Technology Advances with First Patient Enrollments
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.